Results 51 to 60 of about 38,655 (210)

Clinical Relevance of Autoantibodies in Patients with Autoimmune Bullous Dermatosis

open access: yesClinical and Developmental Immunology, 2012
The authors present their experience related to the diagnosis, treatment, and followup of 431 patients with bullous pemphigoid, 14 patients with juvenile bullous pemphigoid, and 273 patients with pemphigus.
Lilla Mihályi   +4 more
doaj   +1 more source

Pemphigoid gestationis and intravenous immunoglobulin therapy

open access: yesInternational Journal of Women's Dermatology, 2018
Pemphigoid gestationis, which is also known as herpes gestationis, is a rare, pregnancy-associated, autoimmune bullous disease. Treatment depends on the severity of the disease for each patient and the safety and use of these drugs during pregnancy and ...
Anes Yang, MD, BMed, MPH   +2 more
doaj   +1 more source

The Rare Presentation of Deep Dermatophytosis‐Trichophyton in an Immunosuppressed Patient

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Dermatophytes typically cause superficial skin infections characterized by an active border. However, they can present atypically invading deeper in immunocompromised patients. We present a case of a 72‐year‐old woman with bullous pemphigoid who had received oral prednisolone for 3 months and developed umbilicated papules.
Jidapa Triwatcharikorn   +3 more
wiley   +1 more source

A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis

open access: yesJournal of Dermatological Treatment
Aim: Bullous pemphigoid induced by secukinumab in treatment of psoriasis is rare.Methods: We report a 49-year-old man with psoriasis who developed bullous pemphigoid during treatment with secukinumab.Results: Scattered tense vesicles with itching ...
Guanghan Wang   +3 more
doaj   +1 more source

Histopathological Aspects of Common Immune Checkpoint Inhibitors Induced Skin Toxicities

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background The histological characteristics of checkpoint inhibitors‐related adverse events (cirAEs) are not well studied and there are conflicting data regarding their similarities and differences with their idiopathic counterparts. Objectives To investigate the histological characteristics of the most common cirAEs.
Christina Kemanetzi   +12 more
wiley   +1 more source

Localized flexural bullous pemphigoid

open access: yesIndian Journal of Dermatology, 2008
A 63-year-old male agriculturist presented with a spontaneously appearing bullous eruption localized to the axillae and groins, with intense pruritus of 3 weeks duration. He was also a known hypertensive, diagnosed with renal failure on treatment with ACE inhibitors and amlodepin since 1 year.
Mehta Vandana, Balachandran C
openaire   +3 more sources

Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis

open access: yesPLoS ONE, 2022
Objective To systematically evaluate the prognostic factors for mortality in bullous pemphigoid. Methods PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, China Biology Medicine disc and Wanfang Database were searched to collect ...
Xianxia Chen   +6 more
doaj   +2 more sources

Interaction of Psoriasis and Bullous Diseases

open access: yesFrontiers in Medicine, 2018
Patients with psoriasis are frequently complicated with autoimmune bullous diseases, especially, pemphigoid diseases. It has been known that one-third cases of anti-laminin gamma1 pemphigoid, formerly anti-p200 pemphigoid, are associated with psoriasis ...
Teruki Dainichi   +2 more
doaj   +1 more source

Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2014
BACKGROUND: aAlthough rare, bullous pemphigoid (BP) is the most common autoimmune blistering disease. Recent studies have shown that patients with bullous pemphigoid are more likely to have neurological and psychiatric diseases, particularly prior to the
Vera Barreto Teixeira   +4 more
doaj   +1 more source

Response to Oral Dapsone in a Patient With Generalised Junctional Epidermolysis Bullosa

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions. Herein, we report a case of intermediate junctional epidermolysis bullosa that improved significantly with oral 4,4’‐diamino‐diphenyl ...
Shiho Mori   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy